Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta‐analysis and GRADE evaluation

Twenty per cent of patients with plaque psoriasis also have psoriatic arthritis – a disease affecting joints and entheses. Different treatment options exist but currently no succinct systematic overview exists. A systematic review of approved systemic treatments for psoriatic arthritis was conducted...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2019-07, Vol.33 (7), p.1249-1260
Hauptverfasser:	Dressler, C., Eisert, L., Pham, P.A., Nast, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Arthritis, Psoriatic - drug therapy Dermatologic Agents - therapeutic use Drug Therapy, Combination Humans Immunosuppressive Agents - therapeutic use Infliximab - therapeutic use Leflunomide - therapeutic use Methotrexate - therapeutic use Randomized Controlled Trials as Topic Sulfasalazine - therapeutic use Thalidomide - analogs & derivatives Thalidomide - therapeutic use Ustekinumab - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!